Document is current

Any future updates will be listed below

Gemcitabine fixed-dose rate infusion for the treatment of pancreatic carcinoma: a meta-analysis of randomized controlled trials

Crossref DOI link: https://doi.org/10.1186/s13000-014-0214-8

Published Online: 2014-11-25

Published Print: 2014-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark